From Academic Induction to Community Dosing: Building a Workflow That Works

In this segment, our panel addresses the practical realities of administering tebentafusp week after week, including how leading centers have built workflows that allow patients to transition from academic induction to community-based ongoing dosing without interrupting treatment continuity. You will hear how panelists approach the conversation about local transition, what travel distance threshold typically prompts that discussion, and what proportion of patients are successfully managed closer to home after completing induction. The panel also discusses the post-infusion observation requirement in pragmatic terms, addresses whether premedication protocols could eventually support more outpatient-friendly administration, and emphasizes why minimizing gaps in weekly dosing particularly in the early months of treatment is critical to maintaining the benefit this therapy can provide.